Global Colloidal Nanoparticles 麻豆原创 Research Report 2025

Publication ID:

PB503258171

Publication Date:

March 20, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Colloidal Nanoparticles was valued at US$ 158 million in the year 2024 and is projected to reach a revised size of US$ 236 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Colloidal nanoparticles are nanometer-sized particles (typically 1鈥�100 nm) that are suspended in a liquid medium, forming a colloidal dispersion. These nanoparticles exhibit unique physical, chemical, optical, and electronic properties due to their high surface-area-to-volume ratio and quantum effects, making them valuable in various scientific and industrial applications.
North American market for Colloidal Nanoparticles is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Colloidal Nanoparticles is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Colloidal Nanoparticles include BBI Solutions, Cytodiagnostics, Fortis Life Sciences, Meliorum Technologies, TANAKA PRECIOUS METAL, Merck KGaA, Nanopartz, CD Bioparticles, Nano Labs, Nanocs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Colloidal Nanoparticles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloidal Nanoparticles.
The Colloidal Nanoparticles market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Colloidal Nanoparticles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colloidal Nanoparticles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BBI Solutions
Cytodiagnostics
Fortis Life Sciences
Meliorum Technologies
TANAKA PRECIOUS METAL
Merck KGaA
Nanopartz
CD Bioparticles
Nano Labs
Nanocs
Segment by Type
Silver Nanoparticles
Gold Nanoparticles
Others
Segment by Application
Imaging
Targeted Drug Delivery
Proton Therapy
In Vitro Testing
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Colloidal Nanoparticles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Colloidal Nanoparticles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Colloidal Nanoparticles 麻豆原创 Overview
1.1 Product Definition
1.2 Colloidal Nanoparticles by Type
1.2.1 Global Colloidal Nanoparticles 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Silver Nanoparticles
1.2.3 Gold Nanoparticles
1.2.4 Others
1.3 Colloidal Nanoparticles by Application
1.3.1 Global Colloidal Nanoparticles 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Imaging
1.3.3 Targeted Drug Delivery
1.3.4 Proton Therapy
1.3.5 In Vitro Testing
1.3.6 Others
1.4 Global Colloidal Nanoparticles 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Colloidal Nanoparticles Revenue 2020-2031
1.4.2 Global Colloidal Nanoparticles Sales 2020-2031
1.4.3 Global Colloidal Nanoparticles 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Colloidal Nanoparticles 麻豆原创 Competition by Manufacturers
2.1 Global Colloidal Nanoparticles Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Colloidal Nanoparticles Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Colloidal Nanoparticles Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Colloidal Nanoparticles, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Colloidal Nanoparticles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Colloidal Nanoparticles, Product Type & Application
2.7 Global Key Manufacturers of Colloidal Nanoparticles, Date of Enter into This Industry
2.8 Global Colloidal Nanoparticles 麻豆原创 Competitive Situation and Trends
2.8.1 Global Colloidal Nanoparticles 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Colloidal Nanoparticles Players 麻豆原创 Share by Revenue
2.8.3 Global Colloidal Nanoparticles Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Colloidal Nanoparticles 麻豆原创 Scenario by Region
3.1 Global Colloidal Nanoparticles 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Colloidal Nanoparticles Sales by Region: 2020-2031
3.2.1 Global Colloidal Nanoparticles Sales by Region: 2020-2025
3.2.2 Global Colloidal Nanoparticles Sales by Region: 2026-2031
3.3 Global Colloidal Nanoparticles Revenue by Region: 2020-2031
3.3.1 Global Colloidal Nanoparticles Revenue by Region: 2020-2025
3.3.2 Global Colloidal Nanoparticles Revenue by Region: 2026-2031
3.4 North America Colloidal Nanoparticles 麻豆原创 Facts & Figures by Country
3.4.1 North America Colloidal Nanoparticles 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Colloidal Nanoparticles Sales by Country (2020-2031)
3.4.3 North America Colloidal Nanoparticles Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Colloidal Nanoparticles 麻豆原创 Facts & Figures by Country
3.5.1 Europe Colloidal Nanoparticles 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Colloidal Nanoparticles Sales by Country (2020-2031)
3.5.3 Europe Colloidal Nanoparticles Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Colloidal Nanoparticles 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Colloidal Nanoparticles 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Colloidal Nanoparticles Sales by Region (2020-2031)
3.6.3 Asia Pacific Colloidal Nanoparticles Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Colloidal Nanoparticles 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Colloidal Nanoparticles 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Colloidal Nanoparticles Sales by Country (2020-2031)
3.7.3 Latin America Colloidal Nanoparticles Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Colloidal Nanoparticles 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Colloidal Nanoparticles 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Colloidal Nanoparticles Sales by Country (2020-2031)
3.8.3 Middle East and Africa Colloidal Nanoparticles Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Colloidal Nanoparticles Sales by Type (2020-2031)
4.1.1 Global Colloidal Nanoparticles Sales by Type (2020-2025)
4.1.2 Global Colloidal Nanoparticles Sales by Type (2026-2031)
4.1.3 Global Colloidal Nanoparticles Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Colloidal Nanoparticles Revenue by Type (2020-2031)
4.2.1 Global Colloidal Nanoparticles Revenue by Type (2020-2025)
4.2.2 Global Colloidal Nanoparticles Revenue by Type (2026-2031)
4.2.3 Global Colloidal Nanoparticles Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Colloidal Nanoparticles Price by Type (2020-2031)
5 Segment by Application
5.1 Global Colloidal Nanoparticles Sales by Application (2020-2031)
5.1.1 Global Colloidal Nanoparticles Sales by Application (2020-2025)
5.1.2 Global Colloidal Nanoparticles Sales by Application (2026-2031)
5.1.3 Global Colloidal Nanoparticles Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Colloidal Nanoparticles Revenue by Application (2020-2031)
5.2.1 Global Colloidal Nanoparticles Revenue by Application (2020-2025)
5.2.2 Global Colloidal Nanoparticles Revenue by Application (2026-2031)
5.2.3 Global Colloidal Nanoparticles Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Colloidal Nanoparticles Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BBI Solutions
6.1.1 BBI Solutions Company Information
6.1.2 BBI Solutions Description and Business Overview
6.1.3 BBI Solutions Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BBI Solutions Colloidal Nanoparticles Product Portfolio
6.1.5 BBI Solutions Recent Developments/Updates
6.2 Cytodiagnostics
6.2.1 Cytodiagnostics Company Information
6.2.2 Cytodiagnostics Description and Business Overview
6.2.3 Cytodiagnostics Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cytodiagnostics Colloidal Nanoparticles Product Portfolio
6.2.5 Cytodiagnostics Recent Developments/Updates
6.3 Fortis Life Sciences
6.3.1 Fortis Life Sciences Company Information
6.3.2 Fortis Life Sciences Description and Business Overview
6.3.3 Fortis Life Sciences Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fortis Life Sciences Colloidal Nanoparticles Product Portfolio
6.3.5 Fortis Life Sciences Recent Developments/Updates
6.4 Meliorum Technologies
6.4.1 Meliorum Technologies Company Information
6.4.2 Meliorum Technologies Description and Business Overview
6.4.3 Meliorum Technologies Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Meliorum Technologies Colloidal Nanoparticles Product Portfolio
6.4.5 Meliorum Technologies Recent Developments/Updates
6.5 TANAKA PRECIOUS METAL
6.5.1 TANAKA PRECIOUS METAL Company Information
6.5.2 TANAKA PRECIOUS METAL Description and Business Overview
6.5.3 TANAKA PRECIOUS METAL Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.5.4 TANAKA PRECIOUS METAL Colloidal Nanoparticles Product Portfolio
6.5.5 TANAKA PRECIOUS METAL Recent Developments/Updates
6.6 Merck KGaA
6.6.1 Merck KGaA Company Information
6.6.2 Merck KGaA Description and Business Overview
6.6.3 Merck KGaA Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck KGaA Colloidal Nanoparticles Product Portfolio
6.6.5 Merck KGaA Recent Developments/Updates
6.7 Nanopartz
6.7.1 Nanopartz Company Information
6.7.2 Nanopartz Description and Business Overview
6.7.3 Nanopartz Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nanopartz Colloidal Nanoparticles Product Portfolio
6.7.5 Nanopartz Recent Developments/Updates
6.8 CD Bioparticles
6.8.1 CD Bioparticles Company Information
6.8.2 CD Bioparticles Description and Business Overview
6.8.3 CD Bioparticles Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CD Bioparticles Colloidal Nanoparticles Product Portfolio
6.8.5 CD Bioparticles Recent Developments/Updates
6.9 Nano Labs
6.9.1 Nano Labs Company Information
6.9.2 Nano Labs Description and Business Overview
6.9.3 Nano Labs Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nano Labs Colloidal Nanoparticles Product Portfolio
6.9.5 Nano Labs Recent Developments/Updates
6.10 Nanocs
6.10.1 Nanocs Company Information
6.10.2 Nanocs Description and Business Overview
6.10.3 Nanocs Colloidal Nanoparticles Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nanocs Colloidal Nanoparticles Product Portfolio
6.10.5 Nanocs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Colloidal Nanoparticles Industry Chain Analysis
7.2 Colloidal Nanoparticles Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Colloidal Nanoparticles Production Mode & Process Analysis
7.4 Colloidal Nanoparticles Sales and 麻豆原创ing
7.4.1 Colloidal Nanoparticles Sales Channels
7.4.2 Colloidal Nanoparticles Distributors
7.5 Colloidal Nanoparticles Customer Analysis
8 Colloidal Nanoparticles 麻豆原创 Dynamics
8.1 Colloidal Nanoparticles Industry Trends
8.2 Colloidal Nanoparticles 麻豆原创 Drivers
8.3 Colloidal Nanoparticles 麻豆原创 Challenges
8.4 Colloidal Nanoparticles 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

BBI Solutions
Cytodiagnostics
Fortis Life Sciences
Meliorum Technologies
TANAKA PRECIOUS METAL
Merck KGaA
Nanopartz
CD Bioparticles
Nano Labs
Nanocs

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.